31 completed, 13 unknown, 8 recruiting, 3 not yet recruiting. 45 Not applicable, 4 Phase 4, 2 Phase 3, 1 Early Phase 1, 1 Phase 1.
Follow Primary Prevention: new trials by email Literature Review of Primary Prevention trials Research Report on Primary Prevention
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immune-Mitochondrial Correction in Military Recruits Multivitamin/Mineral supplements, Sodium nucleinate combination - Respiratory Tract Infections (RTI), Meningitis | Not applicable | Not yet recruiting | MIPO Clinic | 200 | 2027-01-01 | 2026-06-29 |
| Advancing Health Equity and Preventive Cardiovascular Care in Indigenous and Remote Communities: a Mobile Healthcare Unit Cardiovascular risk screening, Follow-up of cardiovascular risk factors - Cardiovascular (CV) Risk, Metabolic Health | Not applicable | Recruiting | Laval University | 500 | 2026-02-11 | 2026-10-09 |
| DELphi Procedure for Developing Recommendations for the Implementation of Wearable Devices and Polygenic Risk Scores Wearable Electronic Devices, Polygenic Risk Score | Not yet recruiting | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 10 | 2026-02-01 | 2026-01-23 | |
| A Master Protocol for Semaglutide Effects on Cardiovascular and Obesity-related Outcomes in People With Overweight or Obesity in the Real World No treatment given - Overweight, Obesity | Completed | Novo Nordisk A/S | 285327 | 2025-08-29 | 2026-01-23 | |
| GUIDE-CAC: Statin-Ezetimibe Without Aspirin vs. Statin Monotherapy With Aspirin in High Coronary Calcification Pitavastatin 4mg and ezetimibe 10mg, taken once daily, Pitavastatin 2 mg with aspirin 100 mg, taken once daily. - Primary Prevention, Vascular Calcification | Phase 4 | Recruiting | Asan Medical Center | 7435 | 2025-07-09 | 2025-08-07 |
| LDL-C Optimization Using Inclisiran in Patients in Which Drug-Drug Interactions Limit LDL Lowering Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL - Drug Interactions, Primary Prevention | Phase 4 | Recruiting | University of California, San Diego | 100 | 2025-04-02 | 2026-11-10 |
| Comparison of Intensive Versus Standard Care & Education for Dyslipidemia in Hypertension and Diabetes Patients centralized management and education group - Hypertension, Diabetes Mellitus | Not applicable | Recruiting | Saint Vincent's Hospital, Korea | 348 | 2025-04-01 | 2025-07-01 |
| The Parental Journey. Digital Tool for Security in Parenthood, a Way to Promote Public Health. A Pilot Study. Parenthood - a journey together. Digital tool to increase security in parenthood, a way to promote public health.. - Primary Prevention, Parenting | Not applicable | Not yet recruiting | Vastra Gotaland Region | 30 | 2024-11-01 | 2024-09-19 |
| FIT FIRST Teen - School Intervention Study FIT FIRST Teen - Primary Prevention | Not applicable | Unknown | University of Southern Denmark | 912 | 2024-08-15 | 2024-09-27 |
| Non-pharmacological Prevention of POD in Frailty Elderly Undergoing Elective Surgery Applied by Nursing Teams Non-pharmacological intervention - Frail Elderly Syndrome, Primary Prevention | Not applicable | Recruiting | Pontificia Universidad Catolica de Chile | 400 | 2024-04-01 | 2025-06-10 |
| Clinical Comparison of Low-dose Rosuvastatin Plus Ezetimibe Combination Therapy and High-dose Rosuvastatin Monotherapy in Patients With Minimal to Intermediate Coronary Artery Disease Without Percutaneous Coronary Intervention Combination drug group of Ezetimibe 10 mg/Rosuvastatin 5 mg, Mono drug group of Rosuvastatin 20 mg - Coronary Artery Disease, Dyslipidemias | Phase 4 | Recruiting | Saint Vincent's Hospital, Korea | 6356 | 2024-02-01 | 2025-06-25 |
| Multicentre Randomised Study Comparing a Taurolidine Lock and a Standard Saline Lock in Paediatric Oncology TaurolockTM, Physiological serum - Children, Medical Device | Not applicable | Recruiting | Institut Curie | 148 | 2024-01-19 | 2026-02-20 |
| Role of Coronary CTA on Lipid Management and Risk Factors Control in an Asymptomatic Chinese Population Coronary Computed Tomography Angiography, Traditional cardiovascular risk stratification - Statin, Cardiovascular Risk Factors | Not applicable | Recruiting | Zhang longjiang,MD | 3400 | 2023-06-28 | 2024-11-26 |
| Strategy for Cardiovascular Disease Prevention Through Tailored Health Management in Individuals With Elevated Risk Village doctor-led tailored health management - Cardiovascular Diseases, Risk Reduction | Not applicable | Completed | China National Center for Cardiovascular Diseases | 4533 | 2023-03-16 | 2024-08-28 |
| FIT FIRST FOR ALL - The Dose-Response Study FIT FIRST - Primary Prevention | Not applicable | Unknown | University of Southern Denmark | 2400 | 2022-12-10 | 2023-12-22 |
| Personalized Disease Prevention Individualized preventive care recommendations (decision tool) - Primary Prevention, Healthy Aging | Not applicable | Completed | Glen Taksler | 721 | 2022-08-05 | 2026-03-02 |
| Prevention of Neck Pain in Adults With a Back School-Based Intervention. Back School - Neck Pain, Exercise Therapy | Not applicable | Completed | University of Vigo | 57 | 2022-03-14 | 2023-05-08 |
| Project Breast47: Effect of an Educational Intervention Web access - Breast Neoplasm, Primary Prevention | Not applicable | Completed | University of Oviedo | 451 | 2022-01-15 | 2024-10-29 |
| Increasing the Impact of a School Prevention Program Among Young Adolescents by Adding a Teacher Component Experimental: "Young Millie" prevention program, active teachers, Prevention program: "Young Mili", non active teachers - Primary Prevention | Not applicable | Unknown | Tel Hai College | 100 | 2021-11-01 | 2021-11-01 |
| A Prevention Program to Encourage Self-care, Self-esteem and Body-esteem Among Young Adolescents Experiment: "Millie" prevention program, adolescents and active parents, Experiment: "Millie" prevention program, adolescents only - Primary Prevention | Not applicable | Unknown | Tel Hai College | 150 | 2021-11-01 | 2021-11-02 |
Showing 20 of 60. Sign in to see all of them.
Cardiovascular Diseases (8) · Diabetes Mellitus (4) · Motor Activity (4) · Obesity (3) · Coronary Artery Disease (2) · Death, Sudden, Cardiac (2) · Dyslipidemias (2) · Genetic Risk Score (2) · Heart Failure (2) · Hypercholesterolemia (2) · Hypertension (2) · Risk Reduction Behavior (2) · Anxiety Disorders (1) · Atherosclerosis (1) · Behavior (1)
Nutritional and Metabolic Diseases (11) · Pathological Conditions, Signs and Symptoms (11) · Metabolic Diseases (9) · Behavior (8) · Cardiovascular Diseases (7) · Pathologic Processes (7) · Vascular Diseases (7) · Glucose Metabolism Disorders (6) · Endocrine System Diseases (5) · Heart Diseases (5) · Signs and Symptoms (5) · Lipid Metabolism Disorders (4) · Arterial Occlusive Diseases (3) · Arteriosclerosis (3) · Body Weight (3)
Aspirin (2) · Primary Prevention (2) · ALN-PCS (1) · CD36 Antigens (1) · Cyclosporine (1) · Endurance Training (1) · Ezetimibe (1) · Geritol (1) · High-Intensity Interval Training (1) · Mass Screening (1) · Nutrition Assessment (1) · Proteins (1) · Resistance Training (1) · Rosuvastatin Calcium (1) · Tai Ji (1)
Tel Hai College (7) · Biotronik SE & Co. KG (2) · Saint Vincent's Hospital, Korea (2) · University of Colorado, Denver (2) · University of Erlangen-Nürnberg Medical School (2) · University of Liege (2) · University of Michigan (2) · University of Southern Denmark (2) · Alar Irs (1) · Asan Medical Center (1) · Centre d'Etudes et de Documentation du Sucre (1) · Centro Cardiologico Monzino (1) · Centro de Estudios, Investigación y Medicina del Deporte (1) · China National Center for Cardiovascular Diseases (1) · Chinese University of Hong Kong (1)
United States (9) · Israel (7) · Germany (5) · Spain (5) · France (4) · South Korea (4) · China (3) · Denmark (3) · Italy (3) · Switzerland (3) · United Kingdom (3) · Belgium (2) · Brazil (2) · Canada (2) · Austria (1)
Dejan Reljic, Dr. (2) · Michelle L Munro-Kramer, PhD,CNM,FNP (2) · Moria Golan, Prof. (2) · Amanda Dempsey, MD, PhD, MPH (1) · Amandine Gofflot (1) · Andrei C Sposito, MD, PhD (1) · Andriana Bertolami, MD, PhD (1) · Anne Krieg, M.D. (1) · Antoinette Birs, MD (1)
PMID 35164721, PMID 12100779, PMID 14520319, PMID 15814585, PMID 18180410, PMID 18778162, PMID 22222120, PMID 24278393, PMID 29912918, PMID 30153820, PMID 30326888, PMID 30480163, PMID 31662372, PMID 32153939, PMID 33310806, PMID 33657870, PMID 33669796, PMID 33762233, PMID 33769555, PMID 35260313, PMID 35551495, PMID 36011572, PMID 36273151, PMID 38066502, PMID 38253469, PMID 38362871, PMID 38750162, PMID 39350195, PMID 40128717, PMID 40425261, PMID 41211018, PMID 41762203, PMID 42184096, PMID 42661433
KL2TR000434 (2), KL2TR002241 (2), K01DA051348 (1), R01AG059979 (1), R21CA230878 (1), R49CE002099 (1), U01IP001091 (1)